Articles

Poll

Podcasts

Slideshows

Videos

Allergy

Allergy condition center page is a comprehensive resource for clinical news and insights on allergic and inflammatory diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for food and seasonal allergies, as well as allergic asthma and related conditions.

Brian Vickery, MD, discusses the mechanism, dose-escalation design, and outlook for a first-in-human microneedle immunotherapy trial for peanut allergy.

Q&A: Inside the First-in-Human Peanut Allergy Microneedle Stamp Trial

Investigators outline how phase 1 safety data could inform a phase 2 efficacy study and eventual pediatric enrollment down to age 4 years.

Microneedle Peanut Allergy Trial Charts Path to Pivotal Testing

The first-in-human study is testing an ascending-dose microneedle device designed to deliver peanut protein through the skin in just 3 minutes.

Microneedle Stamp Enters Phase 1 Trial for Peanut Allergy Immunotherapy

An international 35-expert Delphi panel reached consensus on 33 of 35 statements on precautionary allergen labelling reference doses.

WAO Delphi Consensus Endorses ED05-Based Allergen Labelling

A FORWARD cohort study of 1,359 children found race, income, health literacy, and neighborhood deprivation each predicted food allergy resolution.

Race, Income, and Health Literacy Tied to Food Allergy Resolution

Rima Rachid, MD, discusses the purified MTT formulation, phase 2 trial design, and the gut bacteria driving protection against peanut allergy.

Q&A: Microbiota Transplantation Therapy Simplifies Dosing for Peanut Allergy

Rima Rachid, MD, explains how bile acid metabolism and Bacteroides colonization drive durable Treg cell induction after FMT for peanut allergy.

Fecal Transplant Sustains Peanut Allergy Protection to 12 Months

Rima Rachid, MD, discussed why antibiotic pretreatment before fecal microbiota transplantation may improve peanut allergy response rates.

Antibiotic Pretreatment Improves FMT Response in Peanut Allergy

Merve Karaca Şahin, MD, discusses fear- and picky-eating-driven ARFID behaviors in children with food allergy.

Q&A: Fear, Not Appetite Loss, Drives ARFID Eating Patterns in Food Allergy

A prospective cohort study found 94% of patients tolerated direct initiation at maintenance OIT dosing after brief omalizumab pretreatment.